PreveCeutical Medical Inc.'s shareholders approved the company's 5-for-1 forward stock split at the annual general and special meeting of the shareholders on May 14.
The record date for the split will be May 24, subject to approval of the Canadian Securities Exchange.
On May 30, the company's transfer agent will issue the additional shares to the shareholders of record as of May 24.
